1 / 12

FDA Public Meeting The Future of the International Conference on Harmonization of Technical

FDA Public Meeting The Future of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH). Overview of ICH: A description of the structure and harmonization process. Christelle Anquez* Office of International Programs,

yuma
Download Presentation

FDA Public Meeting The Future of the International Conference on Harmonization of Technical

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. FDA Public Meeting The Future of the International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use (ICH) Overview of ICH: A description of the structure and harmonization process. Christelle Anquez* Office of International Programs, Office of Commissioner *The views expressed in this presentation are those of the presenter’s and do not necessarily represent the views of the U.S. Food and Drug Administration.

  2. I C HINTERNATIONALCONFERENCE ONHARMONISATIONof Technical Requirements for the Registration of Pharmaceuticals for Human Use

  3. A Unique Approach • Agreement between the European Union, Japan and the USA to take action on Harmonisation • A joint initiative involving regulators and industry as equal partners in technical discussions

  4. Inauguration of ICH April 1990, EFPIA Offices, Brussels First meeting of the Six Parties, and IFPMA • To plan an International Conference • To establish Terms of Reference • To establish a Method of Working

  5. ICH Objectives • Identification and elimination of the need to duplicate studies to meet different regulatory requirements. • More efficient use of resources (human, animal, material) in the R&D process, as a consequence. • Quicker access to patients of safe and effective new medicines.

  6. Three Regions, Six Parties Europe EU EFPIA Japan MHLW JPMA The United States of America FDA PhRMA

  7. ICH Organisation Administrative Technical • The ICH Steering committee • ICH Coordinators • The ICH Secretariat (IFPMA) • Expert Working Groups

  8. Steering CommitteeMeeting Attendees • TWO MEMBERS FROM EACH OF THE SIX ICH PARTIES • IFPMA (Secretariat) • OBSERVERS from Canada, EFTA and WHO Oversees and monitors the Harmonisation Process.

  9. Expert Working Groups SAFETY EFFICACY QUALITY REGULATORY COMMUNICATIONS An EWG for each ICH Topic Six Topic Leaders - one from each ICH party Role: developing consensus on technical issues

  10. I C HINTERNATIONALCONFERENCE ONHARMONISATIONGUIDELINEShttp://www.fda.gov/cder/guidance/index.htm

  11. The Five Steps in the ICH Process for Harmonization of Technical Issues STEP 5 : Implementation in the three ICH regions (Federal Register Notice Post on CDER Website) STEP 4 : Agreement on a harmonized ICH guideline; adopted by regulators STEP 3 : Regulatory consultation in the three regions. Consolidation of the comments (Federal Register Notice / Post on CDER Website) STEP 2 : Agreement by the Steering Committee to release the draft consensus text for wider consultation STEP 1 : Building scientific consensus in joint regulatory/industry expert working groups

  12. INTERNATIONAL CONFERENCE ON HARMONIZATION • First Conference: Brussels 1991 • Second Conference: Orlando 1993 • Third Conference: Yokohama 1995 • Fourth Conference: Brussels 1997 • Fifth Conference: San Diego 2000 • Sixth Conference: Osaka 2003

More Related